Abstract:Background: Studying microvessel density (MVD) as an angiogenesis indicator enhances insights into tumor diversity, predicting invasive or metastatic tendencies. It assists in tailoring treatment approaches based on angiogenesis expression in different tumors. Objectives: This study aimed at assessing MVD using the CD31 marker and its associated factors in individuals with endometrial malignancies. Methods: This cross-sectional study involved 118 patients with endometrial cancer (EC) at Imam Hussein Educational and Medical Center, Tehran, Iran spanning from 2018 to 2023. Data, gathered from patient medical files using a researcher-made checklist, included a quantitative assessment of angiogenesis using the CD31 endothelial marker for MVD. Linear regression models were utilized to identify predictors of MVD-CD31 in patients with EC. Results: Patients had a mean age of 57.35 ± 11.16 years. The overall mean MVD-CD31 was 157.06 ± 94.31 (range, 32 - 385). Those with over 50% invasion depth exhibited a higher MVD-CD31 (79.59 units) compared to those with no invasion depth (P = 0.003). Higher MVD-CD31 levels were also associated with lymph node involvement and metastasis to other organs (P < 0.001). In comparison to grade 1 tumors, grade 2 tumors showed elevated MVD-CD31 (mean difference: 64.85, P = 0.007). Clear cell carcinoma tumor type had significantly higher MVD-CD31 than low-grade endometrioid carcinoma (mean difference: 225.84, P = 0.005). Conclusions: Our results suggest that some tumor characteristics such as invasion depth, lymph node involvement, tumor grade, and tumor type may play a role in angiogenesis in patients with EC. These findings suggest that tumor features play a crucial role in modulating angiogenesis in EC.

The study of the density of microvessels in endometrial carcinoma

Prognostic Significance of Microlymphatic Vessel Density and Microvascular Density in Colorectal Carcinoma

The Relationship Between the Microvessel Density and Clinical Pathologic Status in Patients with Esophageal Carcinoma

Influence of Peritumoral Micro-lymphatic Vessel Density on Prognosis of Patients with Endometrial Carcinoma

Clinical significance of microvessel density and vascalar endothelial growth factor in primary breast cancer

The correlation of VEGF expression with MVD in renal pelvic carcinoma and its clinical significance

[Correlation of Tumor Microvessel Density to Metastasis and Recurrence of Rectal Cancer].

A study on thymidine phosphorylase in endometrial carcinoma

Relationship Between Vascular Endothelial Growth Factor and Microvascular Density with Lymph Node Metastasis in Breast Carcinoma

The relationship between microvessel density derived from transitional cell carcinonma of bladder tissues and its biological behavior and prognosis

[Study on the Relationship Between Microvascular Density and Prognosis in Laryngeal Cancer].

High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study

[Expression of Microvessel Density in Multistep Tissues of Gastric Carcinoma and Significance Thereof].

The Relationship Between Lymphatic Microvessel Density and Clinical Pathology of Gastric Carcinoma

Prognostic Significance of Microvessel Density in Intrahepatic Cholangiocarcinoma

Expression and significance of microvessel density in lesions of adenomyosis

Expressions of Matrix Metalloproteinases-2 and Its Tissue Inhibitor-2 and Microvessel Density in Endometrial Carcinoma

Primary study of expression and correlationships of survivin protein and CD34 in endometrial carcinoma tissue

Microvessel Density Assessment and Related Factors in Patients with Endometrial Cancer: A Cross-Sectional Study

Clinical significances and relationship between vascular endothelial growth factor expression and microvessel density in gastric carcinoma

Relationship of adrenomedullin expression with microvessel density and prognosis in carcinoma of endometrium